Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases

Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in antibody production. These patients suffer from recurr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Kobrynski L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/5352b791509b4c489e7611f4de1324f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!